Price
Target price
€0.091
€0.091
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Cytophage Technologies Ltd. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Cytophage Announces Non-Brokered Private Placement
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES
WINNIPEG, October 17, 2025 — Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV: CYTO, FSE: 70G) today
Cytophage Announces the Commercialization of OvaPhage in Canada Through W.L.T. Distributors Inc.
Winnipeg, Manitoba – October 16, 2025 – Cytophage Technologies Ltd. (“Cytophage” or the “Company”), a biotechnology company developing innovative bacteriophage solutions for animal and human
Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission
WINNIPEG, September 29, 2025 — Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV: CYTO, FSE: 70G) announced its participation in the Canadian biomanufacturing mission held in